Oral chronic graft-versus-host disease following allogeneic conventional myeloablative versus non-myeloablative stem cell transplantation

被引：0
|
作者：
Demarosi, F [1 ]
Soligo, D [1 ]
Carrassi, A [1 ]
Deliliers, GL [1 ]
Manusè, I [1 ]
Minazzi, C [1 ]
Sardella, A [1 ]
机构：
[1] Univ Milan, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [21] Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS
    Kok, Laurence M. C.
    Bungener, Laura
    De Bock, Geertruida H.
    Biswana, Anouschka
    Van der Wal, Geertiena
    Van Imhoff, Gustaaf W.
    Bellido, Mar
    HUMAN CELL, 2020, 33 (01) : 243 - 251
  • [22] Non-myeloablative stem cell transplantation (NST) is associated with reduced inflammatory cytokine storm and a decreased incidence of acute graft-versus-host disease (AGVHD) compared to myeloablative stem cell transplantation (MST).
    Reddy, V
    Garraway, KE
    Schold, J
    Kielbasa, J
    Mossak, H
    Randolph, J
    Aronsohn, A
    Rizvi, M
    Wingard, J
    BLOOD, 2003, 102 (11) : 243A - 243A
  • [23] Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation
    Gjaerde, Lars Klingen
    Ostrowski, Sisse Rye
    Minculescu, Lia
    Andersen, Niels Smedegaard
    Friis, Lone Smidstrup
    Kornblit, Brian
    Petersen, Soren Lykke
    Schjodt, Ida
    Sengelov, Henrik
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (03) : 417 - 424
  • [24] Non-Myeloablative Allogeneic Stem Cell Transplant in Acute Myeloid Leukemia: Graft-Versus-Host Disease Potentiates Graft-Versus-Leukemia Effect and Improves Overall Survival
    Pizzola, Christopher J.
    Rakszawski, Kevin L.
    Ehmann, W. Christopher
    Rybka, Witold B.
    Wirk, Baldeep
    Naik, Seema
    Zheng, Hong
    Silar, Brook
    Mackey, Gina
    Mineishi, Shin
    Minagawa, Kentaro
    Claxton, David F.
    BLOOD, 2019, 134
  • [25] HIGH RATES OF NON-RELAPSE MORTALITY AND GRAFT-VERSUS-HOST DISEASE IN PATIENT UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION (ASCT) FOLLOWING NON-MYELOABLATIVE (NMA) CONDITIONING WITH TLI/ATG
    Kanate, A. S.
    Chaudhary, L.
    Cumpston, A.
    Leadmon, S.
    Bunner, P.
    Bulian, D.
    Gibson, L.
    Tse, W.
    Abraham, J.
    Remick, S.
    Craig, M.
    Hamadani, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S313 - S313
  • [26] Early reconstitution of natural killer cells following non-myeloablative hematopoietic stem cell transplantation predicts the development of acute graft-versus-host disease.
    Boyiadzis, Michael
    Hakim, Frances T.
    Memon, Sarfraz A.
    Dean, Robert
    Fowler, Daniel
    Gress, Ronald E.
    Bishop, Michael R.
    BLOOD, 2006, 108 (11) : 816A - 816A
  • [27] Donor response to G-CSF is the best predictive factor of extensive chronic graft-versus-host disease after non-myeloablative allogeneic peripheral blood stem cell transplantation
    Dhedin, N.
    Prebet, T.
    Rea, D.
    Tanguy, M.
    Kuentz, M.
    Piard, N.
    Norol, F.
    Jouet, J. P.
    Rubeil, J. A.
    Tabrizi, R.
    Rio, B.
    Lioure, B.
    Tiberghien, P.
    Bourrhis, J. H.
    Sirvent, A.
    Bordigoni, P.
    Blaise, D.
    Michallet, M.
    Vernant, J. P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S228 - S228
  • [28] Myeloablative haploidentical hematopoietic stem cell transplantation using basiliximab for graft-versus-host disease prophylaxis
    Huang, Rui
    Tu, Sanfang
    Deng, Lan
    Kang, Qian
    Song, Chaoyang
    Li, Yuhua
    HEMATOLOGY, 2015, 20 (06) : 313 - 319
  • [29] In stem cell transplantation by limiting the morbidity of graft-versus-host disease tolerance to myeloablative conditioning is improved
    Novitzky, Nicolas
    Thomas, Valda
    du Toit, Cecile
    Mcdonald, Andrew
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) : 709 - 718
  • [30] Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld, E.
    Weiss, L.
    Kasir, J.
    Zeira, M.
    Slavin, S.
    Shapira, M. Y.
    BONE MARROW TRANSPLANTATION, 2006, 38 (05) : 359 - 364
12345